Tallac Therapeutics

Tallac Therapeutics is a biotech company in Burlingame, United States, founded in 2018. It has raised $182.0M across 2 rounds, most recently a $120.0M Series B in May 2024.

Tallac Therapeutics, Inc – Landing page

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$182.0M
Last Round
$120.0M Series BMay 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.

About

Tallac Therapeutics is a privately held clinical-stage biopharmaceutical company based in Burlingame, California, focused on harnessing innate and adaptive immunity to fight cancer. The company's proprietary Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform delivers a potent TLR9 agonist for targeted immune activation via systemic administration, enabling a new class of immunotherapy candidates for solid tumor malignancies. Founded in 2018 by Drs. Corey Goodman and Hong I. Wan along with two co-founders, Tallac raised $62 million in Series A financing in 2020 and subsequently closed additional rounds to fund its clinical pipeline.

Summary

It lists 11–50 employees. It has raised $182.0M in total across 2 rounds, most recently a $120.0M Series B round in May 2024. Investors include TCGX, Horizon Technology Finance and venBIO Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BMay 2024
$120.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tallac Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/tallac-therapeutics"><img src="https://indexed.vc/api/badge/company/tallac-therapeutics" alt="Tallac Therapeutics on Indexed.vc" width="260" height="76" /></a>